ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,127.79
1.26%
Dow Jones
38,675.68
1.18%
US Dollar vs MXN
16.9724
0.00%
Brent Oil
82.765
0.00%
Bitcoin
62,789.07
-0.16%
Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NYSE
  6. Haemonetics Corp (HAE)

  7. Haemonetics Corp (HAE) Noticias

HAE Haemonetics Corp

94.40
1.07 (1.15%)
03 May 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Haemonetics Corp HAE NYSE Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
1.07 1.15% 94.40 19:00:00
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
94.52 93.09 94.785 94.40 93.33
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
10/4/202415:58PRNUSHaemonetics Sets Date for Publishing Fourth Quarter and..
04/4/202405:30PRNUSHaemonetics Receives FDA Clearance for New TEG® 6s Global..
01/4/202407:00PRNUSHaemonetics Corporation Completes Acquisition of Attune..
05/3/202405:10EDGAR2Form 8-K - Current report
05/3/202405:00PRNUSHaemonetics Announces Definitive Agreement to Acquire Attune..
21/2/202416:57PRNUSHaemonetics to Present at Raymond James 45th Annual..
21/2/202416:55PRNUSHaemonetics to Present at Citi's 2024 Unplugged Medtech and..
13/2/202414:28EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
09/2/202416:49EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
08/2/202409:21EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
08/2/202405:06EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/2/202405:05EDGAR2Form 8-K - Current report
08/2/202405:00PRNUSHaemonetics 3rd Quarter Fiscal Year 2024 Earnings Release..
23/1/202415:13EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
11/1/202415:05PRNUSHaemonetics Sets Date for Publishing Third Quarter Fiscal..
12/12/202305:09EDGAR2Form 8-K - Current report
12/12/202305:00PRNUSHaemonetics Corporation Completes Acquisition of OpSens Inc.
07/12/202315:05PRNUSHaemonetics to Present at 42nd Annual J.P. Morgan Healthcare..
03/11/202315:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/11/202306:00PRNCAOPSENS OBTIENT UNE ORDONNANCE PROVISOIRE ET DÉPOSE UNE..
02/11/202305:19EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
02/11/202305:16EDGAR2Form 8-K - Current report
02/11/202305:00PRNUSHaemonetics 2nd Quarter Fiscal Year 2024 Earnings Release..
24/10/202315:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/10/202315:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/10/202305:10EDGAR2Form 8-K/A - Current report: [Amend]
10/10/202305:00PRNCAOPSENS SIGNS DEFINITIVE AGREEMENT FOR ITS ACQUISITION BY..
05/10/202315:05PRNUSHaemonetics Sets Date for Publishing Second Quarter Fiscal..
18/9/202315:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/9/202315:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/9/202315:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/9/202311:19EDGAR2Form 144 - Report of proposed sale of securities
11/9/202312:22EDGAR2Form 144 - Report of proposed sale of securities
07/9/202315:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/9/202313:23EDGAR2Form 144 - Report of proposed sale of securities
29/8/202305:30PRNUSHaemonetics Announces European Expansion for VASCADE®..
11/8/202315:10EDGAR2Form S-8 - Securities to be offered to employees in employee..
08/8/202315:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/8/202315:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/8/202315:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/8/202315:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/8/202315:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/8/202315:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/8/202315:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/8/202315:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/8/202305:09EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/8/202305:01EDGAR2Form 8-K - Current report
08/8/202305:00PRNUSHaemonetics 1st Quarter Fiscal Year 2024 Earnings Release..
07/8/202315:19EDGAR2Form 8-K - Current report
07/8/202315:10PRNUSDiane M. Bryant Joins Haemonetics' Board of Directors

Su Consulta Reciente

NYSE
HAE
Haemonetics
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados